Gyre Therapeutics (GYRE) Treasury Shares (2011 - 2026)
Gyre Therapeutics (GYRE) posted quarterly Treasury Shares of $13151.0 for Q4 2023, up 6.57% year-over-year from $12340.0 in Q4 2022, and down 65.37% quarter-over-quarter from $37975.0 in Q2 2023.
Gyre Therapeutics (GYRE) Treasury Shares (2011 - 2026) Analysis & Trends
Gyre Therapeutics (GYRE) has reported Treasury Shares for 11 consecutive years, with $13151.0 the latest figure, recorded in Q4 2023.
- In Q4 2023, Treasury Shares rose 6.57% year-over-year to $13151.0; the TTM figure through Dec 2023 stood at $13151.0 (up 6.57% YoY), while the FY2023 annual figure was $13151.0, up 6.57% from the prior year.
- Treasury Shares slipped to $13151.0 in Q4 2023 per GYRE's latest filing, from $37975.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $1.6 million in Q2 2019 and bottomed at $12340.0 in Q4 2022.
- Historically, Treasury Shares has averaged $810543.8 across 3 years, with a median of $803906.5 in 2019.
- Annual changes were most pronounced in 2019 — Treasury Shares jumped 57.14% — and 2023, when it increased 6.57%.
- Gyre Therapeutics' Treasury Shares stood at $1.6 million in 2019, then slumped by 99.22% to $12340.0 in 2022, then climbed by 6.57% to $13151.0 in 2023.
- Business Quant data shows GYRE's Treasury Shares at $13151.0 in Q4 2023, $37975.0 in Q2 2023, and $12340.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Gyre Therapeutics | 708.31 Mn | 685.47 Mn | 26.90 Mn | 3.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.70 Mn |
| Jun 30, 2026 | 3.70 Mn |
| Mar 31, 2026 | 2.60 Mn |
| Mar 31, 2026 | 2.60 Mn |
| Dec 31, 2025 | 2.60 Mn |
| Dec 31, 2025 | 2.60 Mn |
| Jun 30, 2025 | 2.60 Mn |
| Jun 30, 2025 | 2.60 Mn |
| Mar 31, 2025 | 2.60 Mn |
| Mar 31, 2025 | 2.60 Mn |
| Dec 31, 2024 | 2.60 Mn |
| Dec 31, 2024 | 2.60 Mn |
| Dec 31, 2023 | 13,151.00 |
| Dec 31, 2023 | 13,151.00 |
| Jun 30, 2023 | 37,975.00 |
| Jun 30, 2023 | 37,975.00 |
| Mar 31, 2023 | 12,340.00 |
| Mar 31, 2023 | 12,340.00 |
| Dec 31, 2022 | 12,340.00 |
| Dec 31, 2022 | 12,340.00 |